Basilard BioTech, Inc.

Basilard BioTech is focused on revolutionizing cell and gene therapy (CGT). Their innovative technology platform, Celletto, offers a novel approach to gene delivery that could significantly improve the efficiency and scalability of CGT treatments. Celletto utilizes a nanomechanical method to deliver genetic material into individual human cells. This approach overcomes the limitations of traditional viral and non-viral gene delivery methods, potentially leading to more effective and cost-efficient CGT therapies. Basilard BioTech's technology has the potential to address a wide range of diseases by enabling the precise engineering of cells for therapeutic purposes.

Jobs:

News: